From professional translators, enterprises, web pages and freely available translation repositories.
recommended dose
recommended dose
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
160 µg / dose
160 µg/ dose
Last Update: 2011-10-23
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
alvesco 80 mcg/ dose
alvesco 80 mcg/ dose
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
alvesco 160 mcg/ dose 160 µg
alvesco 160 mcg/ dose 160 µg
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
revised note for guidance on repeated dose toxicity
revised note for guidance on repeated dose toxicity
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
repeat-dose (90 days) toxicity testing
repeat-dose (90 days) toxicity testing
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
alvesco 40 40 µg micrograms/ dose inhalasjonsaerosol, oppløsing
alvesco 40 micrograms/ dose inhalasjonsaerosol, oppløsing
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
alvesco 160 microgrammes, dose solution pour inhalation en flacon pressurisé
alvesco 160 microgrammes, dose solution pour inhalation en flacon pressurisé
Last Update: 2011-10-23
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
liquid within a blister pack live attenuated sag2 strain, minimum of 8log10ccid50* per dose 3
- liquid within a blister pack - live attenuated sag2 strain, minimum of 8log10ccid50* per dose -3
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
points to consider on the requirements for clinical documentation for metered dose inhalers (mdi)
points to consider on the requirements for clinical documentation for metered dose inhalers (mdi)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
position paper on the non-clinical safety studies to support clinical trials with a single low dose of a compound
position paper on the non-clinical safety studies to support clinical trials with a single low dose of a compound
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
concept paper on the development of a cpmp position paper on the non-clinical safety studies to support low dose clinical screening studies in humans
concept paper on the development of a cpmp position paper on the non-clinical safety studies to support low dose clinical screening studies in humans
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
b) não ter sido solicitado o estabelecimento de uma dda (dose diária admissível), de um naeo (nível aceitável de exposição do operador), nem de uma dar (dose aguda de referência) ou, se necessário, estes elementos poderem ser estabelecidos com base no factor de avaliação normalizado 100;
(b) mhux rikjesta jew, jekk huwa meħtieġ, adi (konsum aċċettabbli ta' kuljum), aoel (livell ta' esponiment għall-operatur aċċettabbli) u arfd (doża akuta ta' referenza) jistgħu jiġu stabbiliti skond il-fattur ta' valutazzjoni standard ta' 100;
Last Update: 2012-05-05
Usage Frequency: 1
Quality: